Philip J Budge Selected Research

Philip J Budge Research Topics

9	Filarial Elephantiasis (Lymphatic Filariasis) 01/2023 - 06/2011
4	Infections 01/2022 - 01/2015
3	Loiasis 01/2022 - 11/2018
2	Lymphedema (Milroy Disease) 03/2024 - 01/2013
2	Onchocerciasis 01/2023 - 01/2022
2	COVID-19 01/2023 - 01/2022
1	Hematuria 01/2023
1	Coinfection 07/2022
1	Filariasis 01/2022
1	Elephantiasis 03/2020
1	Schistosomiasis (Bilharziasis) 01/2016
1	Neglected Diseases 01/2016
1	Helminthiasis (Helminthiases) 01/2016
1	Virus Diseases (Viral Diseases) 01/2015

3	AntibodiesIBA 01/2023 - 11/2020
3	AntigensIBA 01/2022 - 11/2018
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	moxidectinIBA 01/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2018
2	Glycoproteins (Glycoprotein)IBA 11/2020 - 11/2018
1	erucylphosphocholineIBA 03/2024
1	Diethylcarbamazine (Hetrazan)FDA Link 01/2023
1	LactonesIBA 01/2023
1	Albendazole (Albenza)FDA Link 01/2023
1	Ivermectin (Mectizan)FDA Link 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	SodiumIBA 07/2022
1	Polysaccharides (Glycans)IBA 11/2020
1	Doxycycline (Periostat)FDA LinkGeneric 03/2020
1	Galectin 2 (LGALS2)IBA 01/2020
1	CarbohydratesIBA 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	AnthelminticsIBA 01/2018

6	Mass Drug Administration 01/2023 - 06/2011
1	Therapeutics 03/2024
1	Aftercare (After-Treatment) 01/2023
1	Drug Therapy (Chemotherapy) 03/2020
1	Ambulatory Care (Outpatient Care) 01/2015
1	Activities of Daily Living (ADL) 01/2013